HLS Therapeutics Inc.

acquired/licensed specialty pharmaceuticals (CNS/psychiatric and cardiovascular)

HLS · TSX · Canada

Public Market Listing

HLSTSX

TSX primary exchange listing

Live quotes, historical charts, and market capitalization for HLS Therapeutics Inc. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Bempedoic acid(Nexletol)
Approved
ATP citrate lyaseSmall molecule
Atherosclerotic Cardiovascular Disease
Approved
Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule
Schizophrenia

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.